标题:Expression of estrogen receptor beta and overall survival in non-small cell lung cancer patients Protocol for a systematic review and meta-analysis of cohort studies
作者:Chen, Haisheng; Yan, Mi; Shi, Wenna; Shi, Jing; Duan, Cunxian; Fan, Qing; Wang, Yanhong; Li, Hui
作者机构:[Chen, Haisheng; Shi, Wenna; Shi, Jing; Duan, Cunxian; Fan, Qing; Wang, Yanhong; Li, Hui] Shandong First Med Univ & Shandong Acad Med Sci, Shandong Ca 更多
通讯作者:Li, H
通讯作者地址:[Li, H]Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Pharm, Jiyan Rd 440, Jinan 250117, Shandong, Peoples R China.
来源:MEDICINE
出版年:2019
卷:98
期:43
DOI:10.1097/MD.0000000000017559
关键词:estrogen receptor beta; non-small cell lung cancer; overall survival
摘要:Background: Lung cancer is the leading cause of cancer-related deaths among males and the second leading cause among females worldwide. Numerous studies have linked estrogen status to lung cancer outcome. However, there are studies with conflicting results about the effect of ERb on survival of lung cancer. The aim of this meta-analysis is to evaluate the prognostic impact of estrogen receptor beta expression on survival among NSCLC patients.; Methods: We will search 15 electronic databases, including PubMed, Web of Science, EMBASE, Cochrane Library, and CNKI from inception to June 1, 2019. We will include all cohort studies comparing overall survival of NSCLC patients with high or low estrogen receptor beta expression. The database searches will be supplemented by searching through citations and references. Two reviewers will independently screen search results to identify eligible articles, complete data collection, and conduct quality assessment. All disagreements will be resolved by an independent third reviewer. Methodological quality of the included studies will be assessed using the Newcastle- Ottawa scale. Discrepancies will be resolved by consensus or by consulting a third author. Metaanalyses will be performed, and findings will be reported according to the preferred reporting items for systematic reviews and metaanalyses (PRISMA) and the meta-analysis of observational studies in epidemiology (MOOSE) guidelines.; Results: The results will be submitted to a peer-reviewed journal for publication.; Conclusion: This review will provide a comprehensive evaluation of the evidence on the prognostic impact of ERb expression among NSCLC patients and will help clinicians find potential treatments based on estrogen signaling.
收录类别:SCOPUS;SCIE
资源类型:期刊论文
原文链接:https://www.scopus.com/inward/record.uri?eid=2-s2.0-85074105895&doi=10.1097%2fMD.0000000000017559&partnerID=40&md5=65fa4bd9e90fc1d7ea872fd06ab9d361
TOP